Velmanase alfa®

Active substance

Velmanase alfa

Holder

Chiesi Farmaceutici S.p.A.

Status

Running

Indication

Treatment of non-neurological manifestations in patients with mild to moderate alpha-mannosidosis

Public documents

Approbation

Information for the patient

Informed consent

Last update

10/07/2018

Last updated on 13/04/2021